Reversible Male Birth Control Injectable Lasts 2 Years, Moves to Phase 2 Human Trials Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human trials for their innovative reversible male birth control injectable. This breakthrough technology offers men the opportunity to take charge of their reproductive choices without the need […]